IDEXX Laboratories Inc (IDXX)
418.56
0.00 (0.00%)
USD |
NASDAQ |
Nov 22, 11:23
IDEXX Laboratories Total Assets (Quarterly): 3.351B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 3.351B |
| June 30, 2024 | 3.415B |
| March 31, 2024 | 3.354B |
| December 31, 2023 | 3.260B |
| September 30, 2023 | 3.086B |
| June 30, 2023 | 2.871B |
| March 31, 2023 | 2.808B |
| December 31, 2022 | 2.747B |
| September 30, 2022 | 2.640B |
| June 30, 2022 | 2.607B |
| March 31, 2022 | 2.593B |
| December 31, 2021 | 2.437B |
| September 30, 2021 | 2.386B |
| June 30, 2021 | 2.412B |
| March 31, 2021 | 2.327B |
| December 31, 2020 | 2.295B |
| September 30, 2020 | 2.047B |
| June 30, 2020 | 1.961B |
| March 31, 2020 | 1.886B |
| December 31, 2019 | 1.832B |
| September 30, 2019 | 1.751B |
| June 30, 2019 | 1.724B |
| March 31, 2019 | 1.681B |
| December 31, 2018 | 1.537B |
| September 30, 2018 | 1.545B |
| Date | Value |
|---|---|
| June 30, 2018 | 1.521B |
| March 31, 2018 | 1.469B |
| December 31, 2017 | 1.713B |
| September 30, 2017 | 1.669B |
| June 30, 2017 | 1.637B |
| March 31, 2017 | 1.572B |
| December 31, 2016 | 1.531B |
| September 30, 2016 | 1.500B |
| June 30, 2016 | 1.489B |
| March 31, 2016 | 1.479B |
| December 31, 2015 | 1.475B |
| September 30, 2015 | 1.477B |
| June 30, 2015 | 1.477B |
| March 31, 2015 | 1.431B |
| December 31, 2014 | 1.384B |
| September 30, 2014 | 1.291B |
| June 30, 2014 | 1.283B |
| March 31, 2014 | 1.262B |
| December 31, 2013 | 1.231B |
| September 30, 2013 | 1.195B |
| June 30, 2013 | 1.164B |
| March 31, 2013 | 1.133B |
| December 31, 2012 | 1.104B |
| September 30, 2012 | 1.093B |
| June 30, 2012 | 1.067B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.832B
Minimum
Dec 2019
3.415B
Maximum
Jun 2024
2.616B
Average
2.600B
Median
Total Assets (Quarterly) Benchmarks
| Agilent Technologies Inc | 11.00B |
| Bio-Rad Laboratories Inc | 10.60B |
| Regeneron Pharmaceuticals Inc | 37.44B |
| West Pharmaceutical Services Inc | 3.675B |
| NovaBay Pharmaceuticals Inc | 3.877M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.733B |
| Shareholders Equity (Quarterly) | 1.618B |
| Debt to Equity Ratio | 0.5401 |
| Current Ratio | 1.421 |
| Net Debt Paydown Yield | 0.08% |